TNFα inhibitors as targets for protective therapies in MSA: a viewpoint
Abstract Multiple system atrophy (MSA) is a unique and fatal α-synucleinopathy associated with oligodendroglial inclusions and secondary neurodegeneration affecting striatum, substantia nigra, pons, and cerebellum. The pathogenesis remains elusive; however, there is emerging evidence suggesting a pr...
Main Authors: | Alain Ndayisaba, Kurt Jellinger, Thomas Berger, Gregor K. Wenning |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2019-04-01
|
Series: | Journal of Neuroinflammation |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12974-019-1477-5 |
Similar Items
-
Phytochemicals against TNF<i>α</i>-Mediated Neuroinflammatory Diseases
by: Lalita Subedi, et al.
Published: (2020-01-01) -
Impact of TNF-α Inhibitors on Body Weight and BMI: A Systematic Review and Meta-Analysis
by: Olivia Patsalos, et al.
Published: (2020-04-01) -
The Role of Tumor Necrosis Factor Alpha (TNF-α) in Autoimmune Disease and Current TNF-α Inhibitors in Therapeutics
by: Dan-in Jang, et al.
Published: (2021-03-01) -
Behҫet’s Disease, and the Role of TNF-α and TNF-α Blockers
by: Tim van der Houwen, et al.
Published: (2020-04-01) -
TNF-α Receptor Inhibitor Alleviates Metabolic and Inflammatory Changes in a Rat Model of Ischemic Stroke
by: Shih-Yi Lin, et al.
Published: (2021-05-01)